Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

375 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial.
Keech A, Simes RJ, Barter P, Best J, Scott R, Taskinen MR, Forder P, Pillai A, Davis T, Glasziou P, Drury P, Kesäniemi YA, Sullivan D, Hunt D, Colman P, d'Emden M, Whiting M, Ehnholm C, Laakso M; FIELD study investigators. Keech A, et al. Among authors: kesaniemi ya. Lancet. 2005 Nov 26;366(9500):1849-61. doi: 10.1016/S0140-6736(05)67667-2. Lancet. 2005. PMID: 16310551 Clinical Trial.
A study to determine the response of coronary atherosclerosis to raising low high density lipoprotein cholesterol with a fibric-acid derivative in men after coronary bypass surgery. The rationale, design, and baseline characteristics of the LOCAT Study. Lopid Coronary Angiography Trial.
Syvänne M, Taskinen MR, Nieminen, Manninen V, Kesäniemi YA, Pasternack A, Nawrocki JW, Haber H, Frick MH. Syvänne M, et al. Among authors: kesaniemi ya. Control Clin Trials. 1997 Feb;18(1):93-119. doi: 10.1016/s0197-2456(96)00091-8. Control Clin Trials. 1997. PMID: 9055055 Clinical Trial.
Prevention of the angiographic progression of coronary and vein-graft atherosclerosis by gemfibrozil after coronary bypass surgery in men with low levels of HDL cholesterol. Lopid Coronary Angiography Trial (LOCAT) Study Group.
Frick MH, Syvänne M, Nieminen MS, Kauma H, Majahalme S, Virtanen V, Kesäniemi YA, Pasternack A, Taskinen MR. Frick MH, et al. Among authors: kesaniemi ya. Circulation. 1997 Oct 7;96(7):2137-43. doi: 10.1161/01.cir.96.7.2137. Circulation. 1997. PMID: 9337181 Clinical Trial.
The 5A/6A polymorphism in the promoter of the stromelysin-1 (MMP-3) gene predicts progression of angiographically determined coronary artery disease in men in the LOCAT gemfibrozil study. Lopid Coronary Angiography Trial.
Humphries SE, Luong LA, Talmud PJ, Frick MH, Kesäniemi YA, Pasternack A, Taskinen MR, Syvänne M. Humphries SE, et al. Among authors: kesaniemi ya. Atherosclerosis. 1998 Jul;139(1):49-56. doi: 10.1016/s0021-9150(98)00053-7. Atherosclerosis. 1998. PMID: 9699891 Clinical Trial.
Associations between lipoproteins and the progression of coronary and vein-graft atherosclerosis in a controlled trial with gemfibrozil in men with low baseline levels of HDL cholesterol.
Syvänne M, Nieminen MS, Frick MH, Kauma H, Majahalme S, Virtanen V, Kesäniemi YA, Pasternack A, Ehnholm C, Taskinen MR. Syvänne M, et al. Among authors: kesaniemi ya. Circulation. 1998 Nov 10;98(19):1993-9. doi: 10.1161/01.cir.98.19.1993. Circulation. 1998. PMID: 9808595 Clinical Trial.
375 results